Uncontrolled activity of NEK2A activates several oncogenic pathways and ABC transporters, thereby leading to CIN, cancer cell proliferation, metastasis, and enhanced drug resistance. Here, NEK2 is linked to cervical squamous intraepithelial neoplasia.